{"nct_id":"NCT03668119","title":"A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)","status":"COMPLETED","status_verified_date":"2024-07","start_date":"2018-10-31","start_date_type":"ACTUAL","primary_completion_date":"2022-05-03","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}